Literature DB >> 27764683

Assessing the midwifery workforce demand: Utilising Birthrate Plus in China.

Jiasi Yao1, Xiu Zhu1, Hong Lu2.   

Abstract

OBJECTIVE: To assess the ability of the Birthrate Plus Workforce Planning Methodology (BR+) to forecast midwifery workforce demand in Chinese settings.
DESIGN: A retrospective analysis of medical records.
SETTING: ten hospitals in Beijing District.
METHODS: Hospitals were selected using stratified sampling methods. The client category and midwife hours in each hospital were analysed over 1 month in consecutive three years (2013, 2014, and 2015).
FINDINGS: Client category allocation varied between different hospital levels; Clients in higher category tended to need longer midwife hours; Mean birthrate of the ten hospitals was 154.30 (SD=40.700). Seven out of the ten hospitals were in need of more midwives.
CONCLUSIONS: Birthrate Plus was proved to be effective and efficient in Chinese settings; Gaps between available and needed midwives were large and prevalent in Chinese hospitals.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Keywords:  Birthrate Plus; Midwifery; Workforce projection

Mesh:

Year:  2016        PMID: 27764683     DOI: 10.1016/j.midw.2016.09.007

Source DB:  PubMed          Journal:  Midwifery        ISSN: 0266-6138            Impact factor:   2.372


  2 in total

1.  A cluster-randomized field trial to reduce cesarean section rates with a multifaceted intervention in Shanghai, China.

Authors:  Lulu Zhang; Lin Zhang; Meng Li; Jie Xi; Xiaohua Zhang; Zhenni Meng; Ying Wang; Huaping Li; Xiaohua Liu; Feihua Ju; Yuping Lu; Huijun Tang; Xianju Qin; Yanhong Ming; Rong Huang; Guohong Li; Hongying Dai; Rong Zhang; Min Qin; Liping Zhu; Jun Zhang
Journal:  BMC Med       Date:  2020-02-14       Impact factor: 8.775

2.  Developing a midwifery service task list for Chinese midwives in the task-shifting context: a Delphi study.

Authors:  Yan Ding; Xu Qian; Chunyi Gu; Helena Lindgren; Xiaojiao Wang; Zheng Zhang; Shuang Liang
Journal:  BMJ Open       Date:  2021-07-15       Impact factor: 2.692

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.